SETD7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.125600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.489400E-01
Normal-vs-Stage2
7.155800E-01
Normal-vs-Stage3
8.068600E-01
Normal-vs-Stage4
1.247180E-01
Stage1-vs-Stage2
7.480200E-01
Stage1-vs-Stage3
2.670000E-01
Stage1-vs-Stage4
1.449760E-01
Stage2-vs-Stage3
5.377600E-01
Stage2-vs-Stage4
6.786100E-02
Stage3-vs-Stage4
5.740400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.304800E-01
Normal-vs-AfricanAmerican
4.985800E-01
Normal-vs-Asian
8.611200E-01
Caucasian-vs-AfricanAmerican
3.046800E-01
Caucasian-vs-Asian
3.145800E-01
AfricanAmerican-vs-Asian
2.364800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.763400E-01
Normal-vs-Female
6.267000E-01
Male-vs-Female
5.338000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.818000E-01
Normal-vs-Age(41-60Yrs)
4.351800E-01
Normal-vs-Age(61-80Yrs)
8.597400E-01
Normal-vs-Age(81-100Yrs)
9.290000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.206600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.784200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.048200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.008500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.700200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.389000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.749000E-01
Normal-vs-Daily Drinker
5.941400E-01
Normal-vs-Weekly Drinker
7.450200E-01
Normal-vs-Occasional Drinker
6.192400E-01
Normal-vs-Social Drinker
4.990600E-01
Non Drinker-vs-Daily Drinker
4.454000E-01
Non Drinker-vs-Weekly Drinker
3.357200E-01
Non Drinker-vs-Occasional Drinker
1.821760E-01
Non Drinker-vs-Social Drinker
1.106960E-01
Daily Drinker-vs-Weekly Drinker
1.349970E-01
Daily Drinker-vs-Occasional Drinker
8.018500E-02
Daily Drinker-vs-Social Drinker
5.064200E-02
Weekly Drinker-vs-Occasional Drinker
6.204000E-01
Weekly Drinker-vs-Social Drinker
4.031200E-01
Occasional Drinker-vs-Social Drinker
7.338400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.063400E-01
Normal-vs-Grade 2
5.401900E-02
Normal-vs-Grade 3
6.183500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.054800E-01
Grade 1-vs-Grade 3
5.107000E-01
Grade 1-vs-Grade 4
2.063400E-01
Grade 2-vs-Grade 3
4.934000E-01
Grade 2-vs-Grade 4
5.401900E-02
Grade 3-vs-Grade 4
6.183500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.342000E-01
Normal-vs-NonDiabetic
8.440600E-01
Diabetic-vs-NonDiabetic
9.623400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.286000E-01
Normal-vs-NoPancreatitis
8.084200E-01
Pancreatitis-vs-NoPancreatitis
8.936000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.194400E-01
Normal-vs-N1
6.869000E-01
N0-vs-N1
9.677200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.113600E-01
Normal-vs-TP53-NonMutant
7.075800E-01
TP53-Mutant-vs-TP53-NonMutant
5.738400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
